Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin

Journal of Heart and Lung Transplantation

Volumn 21, Issue 11, 2002, Pages 1237-1241

  Casey, Paul ^a   Garrett, Jeff ^a   Eaton, Tam ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; CEFTAZIDIME; CIPROFLOXACIN; IMMUNOGLOBULIN E; ITRACONAZOLE; PIPERACILLIN; PREDNISONE; TOBRAMYCIN;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BRONCHOPULMONARY ASPERGILLOMA; BRONCHOSCOPY; CASE REPORT; CYSTIC FIBROSIS; DRUG EFFECT; DRUG SENSITIVITY; FORCED EXPIRATORY VOLUME; GENE MUTATION; GENOTYPE; GRAM NEGATIVE INFECTION; HUMAN; LUNG FUNCTION; LUNG TRANSPLANTATION; MALE; NEBULIZER; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TREATMENT OUTCOME; WALKING;

ADMINISTRATION, INHALATION; ADULT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; ITRACONAZOLE; LUNG TRANSPLANTATION; MALE; PREDNISONE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036845820     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00425-4     Document Type: Article

References (21)

1. Egan J.J., Yonan N., Carroll K.B., Deiraniya A.K., et al. Allergic bronchopulmonary aspergillosis in lung allograft recipients. Eur Respir J. 9:1996;169-171.
2. Fitzsimmons E.J., Aris R., Patterson R. Recurrence of allergic bronchopulmonary aspergillosis in the posttransplant lungs of a cystic fibrosis patient. Chest. 112:1997;281-282.
3. International guidelines for the selection of lung transplant candidates. 1998;American Thoracic Society, Auckland, New Zealand.
4. Mroueh S., Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest. 105:1994;32-36.
5. Hanley-Lopez J., Clement L.T. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Curr Opin Pulm Med. 6:2000;540-544.
6. Nepomuceno I.B., Esrig S., Moss R.B. Allergic bronchopulmonary aspergillosis in cystic fibrosis Role of atropy and response to itraconazole . Chest. 115:1999;364-370.
7. Schwartz R.H., Hollick G.E. Allergic bronchopulmonary aspergillosis with low serum immunoglobulin E. J Allerg Immunol. 68:1981;290-294.
8. Maiz L., Cuevas M., Quirce S., Pacheco A., et al. Allergic bronchopulmonary aspergillosis with low serum IgE levels in a child with cystic fibrosis. J Allerg Clin Immunol. 100:1997;431-432.
9. Zeaske R., Bruns T., Fink J.N., et al. Immune responses to Aspergillus in cystic fibrosis. J Allerg Clin Immunol. 82:1988;73-77.
10. Schwartz H.J., Greenberger P.A. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serological and radiological criteria in patients at risk. J Lab Clin Med. 117:1991;138-142.
11. Salez F., Brichet A., Desurmont S., Grosbois J.M., et al. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest. 116:1999;1665-1668.
12. Stevens D.A., Schwartz H.J., Lee J.Y., Moskovitz B.L., et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 342:2000;756-762.
13. Purcell I.F., Corris P.A. Use of nebulised amphotericin B in the treatment of Aspergillus fumigatus empyema. Thorax. 50:1995;1321-1323.
14. Cafferkey M.T. Chemoprophylaxis of invasive pulmonary aspergillosis. J Antimicrob Chemother. 33:1994;917-924.
15. Calvo V., Borro J.M., Morales P., Morcillo A., et al. Antifungal prophylaxis during the early postoperative period of lung transplantation. Chest. 115:1999;1301-1304.
16. Gryn J., Goldberg J., Johnson E., Siegel J., Inzerillo J. The toxicity of daily inhaled amphotericin B. Am J Clin Oncol. 16:1993;43-46.
17. Cory D.B., Grunig G., Hadeiba H., Kurup V.P., et al. Requirements for allergen induced airway hypereactivity in T and B cell deficient mice. Mol Med. 4:1998;344.
18. Prescott S.L., Macaubus C., Smallacombe T., Holt B.J., et al. Development of allergen specific T-cell memory in atopic and normal children. Lancet. 353:1999;196-200.
19. Kauffman H.F., Tomee J.F.C., van de Reit M.A., Timmerman A.J.B., et al. Protease-dependant activation of epithelial cells by fungal allergens leads to morphological changes and cytokine productions. J Allerg Clin Immunol. 105:2000;1185-1193.
20. Wark P., Saltos N., Simpson J., Slater S., et al. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J. 16:2000;1095-1101.
21. Culpitt S.V., Maziak W., Loukidis S., Nightingale J.A., et al. Effect of high dose inhaled steroids on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 160:1999;1635-1639.